I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| plasmacytoid dendritic cell | 12 studies | 29% ± 7% | |
| fibroblast | 10 studies | 21% ± 7% | |
| epithelial cell | 5 studies | 31% ± 14% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 20% ± 1% | |
| natural killer cell | 4 studies | 18% ± 1% | |
| pancreatic A cell | 3 studies | 29% ± 11% | |
| B cell | 3 studies | 18% ± 1% | |
| conventional dendritic cell | 3 studies | 24% ± 6% | |
| precursor B cell | 3 studies | 22% ± 4% | |
| ciliated cell | 3 studies | 23% ± 6% | |
| basal cell | 3 studies | 25% ± 7% | |
| group 3 innate lymphoid cell | 3 studies | 25% ± 4% | |
| connective tissue cell | 3 studies | 32% ± 15% |
